Lv4
434 积分 2021-06-03 加入
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
1小时前
待确认
Development of peptide therapeutics: A nonclinical safety assessment perspective
2天前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
3天前
已完结
Dupilumab-Associated Adverse Events During Treatment of Allergic Diseases
5天前
已完结
Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology
12天前
已完结
TL1A blocking ameliorates intestinal fibrosis in the T cell transfer model of chronic colitis in mice
15天前
已完结
Peptide codes for organ-selective mRNA delivery
25天前
已完结
The Big Four in the Pathogenesis and Pathophysiology of Prurigo Nodularis: Interplay among Type 2 Inflammation, Epidermal Hyperplasia, Dermal Fibrosis, and Itch from Neuroimmune Dysregulation
28天前
已完结
Neonatal Fc Receptor — Biology and Therapeutics
29天前
已完结
Neonatal Fc Receptor — Biology and Therapeutics
29天前
已完结
皖公网安备34019202002308
